Generika Herstellung und Rohstoffe | Afrika, Mittlerer Osten
  • Français
  • Deutsch
  • Home
  • Generics service
    • Full service to local production
    • Raw material supply
    • Dossier development
    • Plant construction
    • Project planning
    • Pharmaceutical development
    • Feasibility studies
    • New molecules
  • About us
    • Generics developer
    • Our Team
    • References + Milestones
    • Business ethics
  • Generics + Biosimilars
    • Product range
    • Human medicine
    • Veterinary medicine
    • Pharmaceutical raw materials
    • Laboratory supplies
  • Service request
Select Page

Clinical trial of a COVID-19 vaccine approved in Germany

Apr 22, 2020 | Medicines

In a press release today, the Paul Ehrlich Institute (PEI) announced that it has approved the first clinical trial of a vaccine against COVID-19 in Germany. It is a ribonucleic acid (RNA) vaccine.

https://www.gelbe-liste.de/nachrichten/corona-impfstoff-klinische-studie

BACK TO NEWS

Categories

  • Counterfeit Medicines (1)
  • Delivery difficulties (3)
  • Development / Dossiers (11)
  • Factory construction (1)
  • Fairs / Events (10)
  • Health (12)
  • Innovation (7)
  • Manufacturing Process (8)
  • Medicines (22)
  • Others (2)
  • Pharmaceutical Raw Materials / Laboratory Equipment (4)
  • Politics (2)
  • Recall (1)
  • Registration Process (3)